270 related articles for article (PubMed ID: 15911214)
1. Effect of experimental pH on the in vitro permeability in intact rabbit intestines and Caco-2 monolayer.
Lee KJ; Johnson N; Castelo J; Sinko PJ; Grass G; Holme K; Lee YH
Eur J Pharm Sci; 2005 Jun; 25(2-3):193-200. PubMed ID: 15911214
[TBL] [Abstract][Full Text] [Related]
2. The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
Liu T; Chang LJ; Uss A; Chu I; Morrison RA; Wang L; Prelusky D; Cheng KC; Li C
J Pharm Biomed Anal; 2010 Apr; 51(5):1069-77. PubMed ID: 20036089
[TBL] [Abstract][Full Text] [Related]
3. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cocktail approach to standardise Caco-2 permeability experiments.
Koljonen M; Hakala KS; Ahtola-Sätilä T; Laitinen L; Kostiainen R; Kotiaho T; Kaukonen AM; Hirvonen J
Eur J Pharm Biopharm; 2006 Nov; 64(3):379-87. PubMed ID: 16914297
[TBL] [Abstract][Full Text] [Related]
5. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
[TBL] [Abstract][Full Text] [Related]
6. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
7. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Yu L; Zeng S
J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
[TBL] [Abstract][Full Text] [Related]
8. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model.
Delie F; Rubas W
Crit Rev Ther Drug Carrier Syst; 1997; 14(3):221-86. PubMed ID: 9282267
[TBL] [Abstract][Full Text] [Related]
9. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
Usansky HH; Sinko PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
[TBL] [Abstract][Full Text] [Related]
10. H+-zwitterionic amino acid symport at the brush-border membrane of human intestinal epithelial (CACO-2) cells.
Thwaites DT; Stevens BC
Exp Physiol; 1999 Mar; 84(2):275-84. PubMed ID: 10226170
[TBL] [Abstract][Full Text] [Related]
11. pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers.
Neuhoff S; Ungell AL; Zamora I; Artursson P
Eur J Pharm Sci; 2005 Jun; 25(2-3):211-20. PubMed ID: 15911216
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa.
Miret S; Abrahamse L; de Groene EM
J Biomol Screen; 2004 Oct; 9(7):598-606. PubMed ID: 15475479
[TBL] [Abstract][Full Text] [Related]
13. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
14. The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models.
Foltz M; Cerstiaens A; van Meensel A; Mols R; van der Pijl PC; Duchateau GS; Augustijns P
Peptides; 2008 Aug; 29(8):1312-20. PubMed ID: 18490081
[TBL] [Abstract][Full Text] [Related]
15. The intestinal permeability of neolignans from the seeds of Myristica fragrans in the Caco-2 cell monolayer model.
Yang XW; Huang X; Ma L; Wu Q; Xu W
Planta Med; 2010 Oct; 76(14):1587-91. PubMed ID: 20391318
[TBL] [Abstract][Full Text] [Related]
16. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers.
Hubatsch I; Ragnarsson EG; Artursson P
Nat Protoc; 2007; 2(9):2111-9. PubMed ID: 17853866
[TBL] [Abstract][Full Text] [Related]
17. Transport mechanisms of flavanone aglycones across Caco-2 cell monolayers and artificial PAMPA membranes.
Kobayashi S; Nagai T; Konishi Y; Tanabe S; Morimoto K; Ogihara T
J Pharm Pharmacol; 2012 Jan; 64(1):52-60. PubMed ID: 22150672
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
[TBL] [Abstract][Full Text] [Related]
19. Preclinical characterization of intestinal absorption and metabolism of promising anti-Alzheimer's dimer bis(7)-tacrine.
Zhang L; Yu H; Li WM; Cheung MC; Pang YP; Gu ZM; Chan K; Wang YT; Zuo Z; Han YF
Int J Pharm; 2008 Jun; 357(1-2):85-94. PubMed ID: 18358649
[TBL] [Abstract][Full Text] [Related]
20. In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Caldwell GW; Easlick SM; Gunnet J; Masucci JA; Demarest K
J Mass Spectrom; 1998 Jul; 33(7):607-14. PubMed ID: 9692244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
